Vor Biopharma Inc. Quarterly Operating Lease, Payments in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vor Biopharma Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
  • Vor Biopharma Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.64M, a 6.15% increase year-over-year.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2023 was $6.66M, a 50% decline from 2022.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2022 was $13.3M, a 420% increase from 2021.
  • Vor Biopharma Inc. annual Operating Lease, Payments for 2021 was $2.56M, a 264% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.64M +$95K +6.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $1.54M +$817K +112% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $727K +$285K +64.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $442K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.